The objective of this study was to investigate the perceived increase in resistance of Streptococcus equi subsp. zooepidemicus (S. zooepidemicus) isolated from the lower respiratory tract of horses to trimethoprim-sulfamethoxazole (SXT). The recorded SXT-susceptibility results of 50 S. zooepidemicus isolates from the tracheal wash fluid of equine patients examined at Colorado State University Veterinary Teaching Hospital from each of 2 time periods (1987-1990 and 1997-2001) were compared and statistically analyzed using a cross-sectional study design. There was a statistically significant difference between the documented resistance of S. zooepidemicus isolated in the 1987-1990 time period (8%), using quantitative microbroth dilution, and the resistance reported for isolates from the 1997-2001 time period (42%), using Kirby-Bauer agar disk diffusion. Laboratory investigation revealed inadequate quality control of media and subsequent falsely reported resistance of S. zooepidemicus from 1997 to 2001 time period. This study demonstrates how minor deviations from prescribed laboratory-testing guidelines can have a major effect on antimicrobial susceptibility test results. The study also underscores the need for regular surveillance and monitoring of trends in antimicrobial susceptibility to detect and correct such problems. In addition, epidemiologists and others collecting data from laboratories should be cautioned to interact with the laboratory regarding interpretation of results of various testing methods to ensure accurate analysis and conclusions.
Antimicrobial resistance is of growing concern to the medical community worldwide, with increased awareness and epidemiological investigation greatly enhancing the detection and monitoring of trends in bacterial resistance to antimicrobials. 2, 4 Trimethoprim-sulfamethoxazole (SXT) and trimethoprim-sulfadiazine form an antimicrobial drug combination (potentiated sulfonamides) widely used in veterinary medicine to treat a range of bacterial infections. Potentiated sulfonamides are a particularly popular choice of antimicrobial drug for use in equine patients for a variety of reasons, including their bactericidal effect against many gram-positive and gram-negative bacteria, oral method of administration, relative safety, and low cost. Potentiated sulfonamides frequently are selected to treat respiratory infections in equine patients, based on knowledge of likely microorganisms and their predicted susceptibilities. 4, 14 Streptococcus equi subsp. zooepidemicus, a Lancefield group C, ␤-hemolytic coccus, is reported to be the most common microorganism recovered from the lower respiratory tract of horses with respiratory disease. 3, 10, 15 Historically, ␤-hemolytic streptococci isolated from equine patients have been considered to be predictably susceptible to beta-lactam and potentiated sulfonamide antimicrobial agents. 6, 14 Consequently, potentiated sulfonamides are frequently a part of the treatment of such infections in horses.
In this study, the authors investigated a reported increase in the resistance of S. zooepidemicus isolated from the lower respiratory tract of equine patients at Colorado State University James L. Voss Veterinary Teaching Hospital to SXT. The motivation behind this study was based on a clinical impression that in the late 1980s the reported susceptibility of S. zooepidemicus isolated from the respiratory tract of equine patients to SXT was close to 100% compared with a reported susceptibility of approximately 50% in more recent years. Potentiated sulfonamides have been used for many decades as effective, practical, relatively safe, and inexpensive agents for the treatment of bacterial infections in animals and humans. 12 However, the development of resistance of certain bacteria to both antimicrobials has gradually reduced their clinical efficacy. 12 Therefore, the purpose of this retrospective study was to determine whether there was increasing resistance of S. zooepidemicus isolated from the lower respiratory tract of horses to SXT. This communication also describes the subsequent laboratory investigation into the bacterial susceptibility testing methods used and the effect on the reported susceptibility of S. zooepidemicus to SXT.
A retrospective study was conducted through the Colorado State University James L. Voss Veterinary Teaching Hospital medical records database, identifying a sample size of 50 S. zooepidemicus susceptibility reports from equine respiratory cases during each of 2 separate time periods: 1987-1990 and 1997-2001 . The numbers of S. zooepidemicus reported as resistant to SXT from each time period were compared and CSU-VDL/MH ϩ 5% SRBC* 26 15 (37) Purdue/MIC † 41 0 (0) CSU-VDL/MH ‡ 7 0 (0) * Isolates (N ϭ 41) initially tested at CSU-VDL were tested using Kirby-Bauer agar disk diffusion using Mueller-Hinton with 5% sheep red-blood cells as the culture medium.
† Isolates (N ϭ 41) tested at Purdue were tested with the Sensititre/ Trek broth dilution method, using laked horse blood added to the Mueller-Hinton broth medium for testing with SXT.
‡ Isolates (N ϭ 7) originally resistant at CSU-VDL retested at the CSU-VDL using Mueller-Hinton agar without blood supplementation.
statistically analyzed using a cross-sectional study design. 5 The authors of this study estimated that this number of samples would allow for adequate power to distinguish a significant difference if the susceptibility to SXT in one time period was 90% compared with 50% in the other time period.
The antimicrobial susceptibility data from this time period showed that 4 of 50 (8%) S. zooepidemicus isolates were reported in the medical record to be resistant to SXT, using the quantitative microbroth dilution (Trek) system. a In the time period 1997-2001, 21 of 50 (42%) S. zooepidemicus isolates were reported in the medical record as resistant to SXT by the laboratory, using Mueller-Hinton with 5% sheep red-blood cells as the culture medium c and incubation in 5% CO 2 at 35ЊC. The Clinical and Laboratory Standards Institute (CLSI, formerly NCCLS) guidelines for susceptibility testing were followed, and results were reported as recommended. 8 This difference was statistically significant on the basis of an odds ratio of 8.3 and a P value of 0.0001.
Subsequent to the results of retrospective analysis the Colorado State University Veterinary Diagnostic Laboratories (CSU-VDL) conducted a thorough evaluation of laboratory media and antimicrobial susceptibility testing methods and quality control procedures. The culture medium used for testing the susceptibility of S. zooepidemicus to SXT, using the Kirby-Bauer disk diffusion technique, was determined to be unsuitable on the basis of recommended quality control procedures. 8 Prescott 9 and others describe problems in laboratory testing of Streptococcus spp., as well as a number of other microorganisms, to diaminopyrimidine-sulfonamide drug combinations as common because of the presence of para-aminobenzoic acid (PABA) or thymidine in whole blood-based media. 1, 8, 9 The recommended microorganisms for quality control analysis of the media for evaluation of a new lot for excessive amounts of thymidine or thymine are Enterococcus faecalis (American Type Culture Collection [ATCC] 29212) b or E. faecalis (ATCC 33186), a more sensitive indicator of thymidine levels. 11 Streptococcus pneumoniae (ATCC 49619) was the microorganism used by the CSU-VDL, as is recommended for quality control when using Mueller-Hinton with blood. Thus, bacterial isolates were being read as either susceptible or resistant on the basis of indistinct zones of growth inhibition.
Further investigation involved comparing the susceptibility of a separate group of 41 S. zooepidemicus isolates of equine origin using both Kirby-Bauer, as performed at the CSU-VDL before this investigation, and broth-microdilution methods. The source of the equine isolates for this part of the study was isolates submitted by the CSU-VDL as 1 of the laboratories participating in a pilot study for a surveillance system for detecting variation in antimicrobial susceptibility of animal pathogens (American Veterinary Medical Association [AVMA] Steering Committee on Antimicrobial Resistance [SCAR], Surveillance System of Antimicrobial Susceptibility for Animal Pathogens project). As part of this study, 10 ␤-hemolytic Streptococcus spp. isolates from 3 participating veterinary diagnostic laboratories for each month of the year from February 2001 until February 2002 were collected for determination of minimum inhibitory concentrations (MIC) at Purdue University. Results from the testing of the 41 equine-origin S. zooepidemicus isolates sent from CSU-VDL as part of the pilot antimicrobial resistance study at Purdue University are given in Table 1 . Seven of the 41 isolates that were reported by CSU-VDL as resistant and by Purdue as susceptible were retested at CSU-VDL using a different media formulation ( Table 1) .
The problem with the testing method for ␤-hemolytic Streptococcus spp. against SXT was not detected after the introduction of the Kirby-Bauer testing method. Results of antimicrobial testing indicate that the increase in resistance reports of S. zooepidemicus to SXT occurred after July 1999, long after Kirby-Bauer was introduced into the laboratory. The reason for the change after this date is unknown, but the manufacturer of the medium indicated that there had been no changes in media formulations. The medium used met quality control standards using S. pneumoniae. However, because the medium was not being tested with the recommended organism (E. faecalis ATCC 33186), 8 the significance of antagonism of whole-blood products in the media used for SXT-susceptibility testing was not detected until the clinical retrospective study was conducted.
Consequent to these findings, laboratory procedure modifications to identify suitable media were pursued. Mueller-Hinton medium supplemented with 5% sheep blood was quality control tested using the recommended microorganism for use with SXT in January 2002, and all tested plates failed to meet quality control. Several other media were checked using the same quality control microorganism. These included Remel Mueller-Hinton with 5% sheep blood, d,e Remel Chocolate Mueller-Hinton, d,e BBL c and Remel Mueller-Hinton, and Haemophilus test medium. All media failed quality control with E. faecalis ATCC 33186. Subsequently, Mueller-Hinton medium without supplementation with blood was tested using E. faecalis ATCC 33186 with SXT. Results of this quality control testing showed that these unsupplemented plates were acceptable on the basis of the appropriate quality control procedures. Concerns regarding the potentially inadequate rate of growth of Streptococcus microorganisms on unsupplemented Mueller-Hinton media resulted in a trial revision of antimicrobial susceptibility testing methods for Streptococcus spp. to SXT in the laboratory until a commercial source began producing Mueller-Hinton agar with 5% lysed horse blood. The temporary methods were to test all ␤-hemolytic Streptococcus spp. on Mueller-Hinton media supplemented with 5% defibrinated sheep red-blood cells for all antimicrobial agents except trimethoprim and sulfamethoxazole. For testing ␤hemolytic Streptococcus spp. with SXT, unsupplemented Mueller-Hinton medium was used, and results were reported if growth was adequate for analysis. Quality control testing was performed consistently and at regular intervals using the recommended microorganisms (E. faecalis ATCC 33186), and only media that passed quality control was used.
Before this investigation, a commercial source for laked horse blood agar was unavailable to the CSU-VDL. Consequently, the laboratory manufactured its own Mueller-Hinton medium with laked horse blood. Although the media with 5% laked horse blood added was within control standards, this media did not remain within quality control for a long enough time period to be a practical source in the laboratory. After identification of a suitable commercial manufacturer for laked horse blood in Mueller-Hinton agar, this source was contracted to supply the CSU-VDL to meet requirements. Currently, testing ␤-hemolytic Streptococcus spp. with trimethoprim and sulfamethoxazole is performed using Mueller-Hinton media supplemented with 5% laked horse blood, e as recommended and approved by CLSI. 8 Quality control is performed as recommended. Since making these modifications, the CSU-VDL has not recognized any previously questionable zones of inhibition on susceptibility plates when testing susceptibility of ␤-hemolytic Streptococcus spp. of equine origin to SXT.
If guidelines such as those given by CLSI are not followed in detail, including the use of the appropriate quality control microorganisms, it can affect susceptibility results by causing zones of growth inhibition to be smaller or less distinct or even result in no zone at all. 11 The published CLSI guidelines recommend using media containing lysed (laked) horse blood or thymidine phosphorylase for testing of ␤-hemolytic Streptococcus spp. with potentiated sulfonamides. 7, 8, 11, 13 The PABA and thymine/thymidine content of Mueller-Hinton Medium and broth are reduced to a minimum, 8 and results with unmodified Mueller-Hinton have been generally satisfactory for the testing of Streptococcus spp. to sulfonamide and trimethoprim. This is a likely explanation for the reported susceptibility of the 7 retested S. zooepidemicus isolates. However, Streptococcus spp. may require enrichment media supplemented with blood or blood products to grow at an adequate rate. 9 There is recent evidence suggesting that a number of microbiology laboratories are failing to comply with CLSI recommendations for quality control of culture media. 16 A survey of 124 laboratories performing testing of human samples in Ontario showed that few laboratories actually followed recommended quality control protocols. Major compliance failures included failure to perform quality control at all and inappropriate choice of bacterial strains and inoculum used for quality control. 16 Although the findings of this survey are not specific for the susceptibility of S. zooepidemicus to SXT as investigated in this report, it may suggest that not all laboratories comply fully with recommended practices. In addition, a survey of veterinary diagnostic laboratories in the United States 2 showed that of 64 laboratories that routinely performed antimicrobial susceptibility testing on veterinary isolates, 65% of isolates were tested using the Kirby-Bauer disk diffusion method. This survey also found that only 84% of laboratories self-reported compliance with CLSI recommendations.
Considering the findings from the above-mentioned surveys and the information learned from this retrospective study and subsequent investigation, further assessment and more rigid control of standard laboratory procedures may be warranted. Although a number of publications clearly describe the laboratory techniques that should be used to obtain the most accurate information regarding antimicrobial susceptibility testing, these guidelines may not be followed in adequate detail to lead to valid testing. Consequently, laboratories may be reporting inaccurate information that can significantly affect antimicrobial drug choices made by clinicians in the treatment of clinical cases. These problems may easily go unrecognized, unless trends in antimicrobial susceptibility patterns are critically evaluated, looking for trends over time and investigating detectable changes that may occur from one time period to another. 
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